A Study to Investigate LDL-cholesterol Lowering With Inclisiran Compared to Bempedoic Acid in Patients With Atherosclerotic Cardiovascular Disease.
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 402 participants.
Also called NCT06431763
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 402 participants
- Sponsor
- Registry
-
NCT06431763
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Germany
- Registry status
- Completed
Technical summary
Registry record NCT06431763. Randomized; no masking; primary purpose treatment. Start 2024-06-21 (actual); primary completion 2025-12-01 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study to Investigate LDL-cholesterol Lowering With Inclisiran Compared to Bempedoic Acid in Patients With Atherosclerotic Cardiovascular Disease.
- Condition
- Hypercholesterolemia
- Intervention (Drug)
- Inclisiran sodium
- Intervention (Drug)
- BPA
- Lead sponsor
- Novartis Pharmaceuticals
Record details
- Record id
cardio:ct-nct06431763- Content hash
dd8c92cd8904c784b4fa78f47d54c7440c8bc2415a284410ad6a6cba83c98351